{"id":"intratracheal-administration-of-surfactant","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Intratracheal administration of surfactant to reduce surface tension in the lungs, facilitating gas exchange and improving lung function in preterm infants with respiratory distress syndrome.","oneSentence":"Surfactant replacement therapy","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:55:23.322Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Respiratory distress syndrome in preterm infants"}]},"trialDetails":[{"nctId":"NCT06855043","phase":"PHASE1, PHASE2","title":"Little Lungs Study","status":"NOT_YET_RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2026-09","conditions":"Invasive Mechanical Ventilation, Severe Respiratory Distress Syndrome","enrollment":24},{"nctId":"NCT07350018","phase":"PHASE4","title":"Calfactant vs Poractant Alfa Using a Less Invasive Technique in Preterm Infants With Respiratory Distress Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Uludag University","startDate":"2026-01-20","conditions":"Respiratory Distress Syndrome in Premature Infants, Respiratory Distress Syndrome (RDS), Surfactant","enrollment":234},{"nctId":"NCT04209946","phase":"NA","title":"Early Caffeine and LISA Compared to Caffeine and CPAP in Preterm Infants","status":"COMPLETED","sponsor":"Sharp HealthCare","startDate":"2020-01-22","conditions":"Premature Lungs, Respiratory Distress Syndrome, Surfactant Deficiency Syndrome Neonatal","enrollment":180},{"nctId":"NCT07235345","phase":"NA","title":"To Investigate the Effect of Pulmonary Surfactant With Different Inspired Oxygen Concentrations on the Clinical Outcomes of Very Preterm Infants Under Non-invasive Assisted Ventilation","status":"ENROLLING_BY_INVITATION","sponsor":"Xu Falin","startDate":"2025-09-04","conditions":"Neonatal Respiratory Distress Syndrome","enrollment":500},{"nctId":"NCT06880016","phase":"NA","title":"Evaluation of Serial Lung Ultrasound Data After Surfactant Treatments Applied With Different Methods in Preterm Babies","status":"RECRUITING","sponsor":"Konya City Hospital","startDate":"2024-07-01","conditions":"Newborn Complication, Respiratory Distress Syndrome, Newborn","enrollment":68},{"nctId":"NCT07098910","phase":"NA","title":"Surfactant Therapy Via Supraglottic Airway to Preterm Neonates With RDS in Vietnam","status":"RECRUITING","sponsor":"Karolinska Institutet","startDate":"2025-09-25","conditions":"Respiratory Distress Syndrome in Premature Infant","enrollment":440},{"nctId":"NCT06606444","phase":"NA","title":"Feasibility Study of Placement and Surfactant Administration Through a Preterm Size Laryngeal Mask Airway in Very Low Birth Weight Neonates With Respiratory Distress Syndrome","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2024-09-20","conditions":"Respiratory Distress Syndrome, Newborn","enrollment":45},{"nctId":"NCT07070167","phase":"","title":"Bedside Ultrasound to Monitor Lung Function and Blood Flow in Newborns Treated With Surfactant","status":"NOT_YET_RECRUITING","sponsor":"Chiesi Poland Sp. z o.o.","startDate":"2025-08-30","conditions":"Lung Ultrasound, Respiratory Distress Syndrome, Newborn","enrollment":200},{"nctId":"NCT05898633","phase":"PHASE1","title":"Recombinant Surfactant Protein D (rfhSP-D) to Prevent Neonatal Chronic Lung Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"University College, London","startDate":"2024-04-06","conditions":"Chronic Lung Disease of Prematurity, Respiratory Distress Syndrome in Premature Infant, Bronchopulmonary Dysplasia","enrollment":24},{"nctId":"NCT06786039","phase":"","title":"Clinical Impact of Non-invasive Neurally Adjusted Ventilatory Assist in Very Preterm Infants","status":"RECRUITING","sponsor":"Korea University Anam Hospital","startDate":"2025-01-20","conditions":"Preterm Infant","enrollment":80},{"nctId":"NCT06758492","phase":"","title":"A Prospective Observational Study of Video Laryngoscopy Versus Direct Laryngoscopy for Insertion of a Thin Endotracheal Catheter for Surfactant Administration in Newborn Infants","status":"RECRUITING","sponsor":"University College Dublin","startDate":"2025-01-13","conditions":"Respiratory Distress Syndrome (Neonatal), Respiratory Distress Syndrome (RDS), Video Laryngoscopy","enrollment":600},{"nctId":"NCT06491901","phase":"NA","title":"Prospective, Non-Blinded, Randomized Controlled Trial on Early Administration of Pulmonary Surfactant Guided by Lung Ultrasound Scores in Very Preterm Infants.","status":"NOT_YET_RECRUITING","sponsor":"Peking University Third Hospital","startDate":"2024-08-01","conditions":"Early Administration of Pulmonary Surfactant Guided by Lung Ultrasound Scores in Very Preterm Infants","enrollment":60},{"nctId":"NCT04662151","phase":"PHASE1","title":"A Clinical Safety Study of AT-100 (rhSP-D) in Preterm Neonates at High Risk for Bronchopulmonary Dysplasia (BPD)","status":"COMPLETED","sponsor":"Airway Therapeutics, Inc.","startDate":"2021-09-01","conditions":"Bronchopulmonary Dysplasia","enrollment":37},{"nctId":"NCT06367881","phase":"PHASE1","title":"Assessment Of Dose-Dependent Immunomodulatory Effect Of Alveofact With or Without Steroisd In Neonatal RDS","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2022-08-18","conditions":"Neonatal Respiratory Distress Syndrome, Inflammatory Response, Premature Lungs","enrollment":60},{"nctId":"NCT03582930","phase":"","title":"Aerosolized Infasurf Treatment Protocol: Aerosolized Infasurf for Spontaneously Breathing Patients With Early RDS (AERO-03)","status":"NO_LONGER_AVAILABLE","sponsor":"ONY","startDate":"","conditions":"Neonatal Respiratory Distress","enrollment":""},{"nctId":"NCT02772081","phase":"PHASE3","title":"A Study in Preterm Neonates With Respiratory Distress Syndrome (RDS) Comparing CUROSURF® Administration Through Less Invasive Surfactant Administration (LISA) and Conventional Administration","status":"TERMINATED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2021-05-18","conditions":"Respiratory Distress Syndrome (RDS)","enrollment":33},{"nctId":"NCT04056741","phase":"PHASE2","title":"Administration of Surfactant Through an Instillation Device Infasurf® (Calfactant) in Neonates- A Pilot Study","status":"SUSPENDED","sponsor":"ONY","startDate":"2025-02-07","conditions":"RDS of Prematurity, Surfactant Protein B Deficiency, Chronic Lung Disease","enrollment":55},{"nctId":"NCT02164734","phase":"PHASE4","title":"Surfactant Via Endotracheal Tube vs. Laryngeal Mask Airway (LMA) in Preterm Neonates With Respiratory Distress Syndrome","status":"TERMINATED","sponsor":"Albany Medical College","startDate":"2014-06","conditions":"Respiratory Distress Syndrome, Newborn","enrollment":93},{"nctId":"NCT04659122","phase":"PHASE1","title":"A Clinical Safety Study on AT-100 in Treating Adults With Severe COVID-19 Infection or Severed Community Acquired Pneumonia","status":"TERMINATED","sponsor":"Airway Therapeutics, Inc.","startDate":"2021-08-17","conditions":"COVID-19, Undefined","enrollment":5},{"nctId":"NCT04502433","phase":"PHASE2","title":"Poractant Alfa (Curosurf®)) -- Effect in Adult Patients Diagnosed With 2019 Novel Coronavirus (SARS-COV-19; (Covid-19)) Acute Respiratory Distress Syndrome (ARDS)","status":"TERMINATED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2021-01-06","conditions":"Acute Respiratory Distress Syndrome","enrollment":22},{"nctId":"NCT03275415","phase":"PHASE4","title":"Intratracheal Budesonide/Surfactant Prevents BPD","status":"COMPLETED","sponsor":"Taipei Medical University","startDate":"2019-07-01","conditions":"Respiratory Distress Syndrome, Bronchopulmonary Dysplasia","enrollment":310},{"nctId":"NCT05534685","phase":"NA","title":"Budesonia + Intratracheal Surfactant in Incidence of Bronchopulmonary Dysplasia","status":"UNKNOWN","sponsor":"Coordinación de Investigación en Salud, Mexico","startDate":"2022-09-20","conditions":"Respiratory Tract Diseases","enrollment":336},{"nctId":"NCT04825197","phase":"PHASE2","title":"Late Surfactant After a Recruitment Maneuver in Extremely Low Gestational Age Newborns - LATE-REC-SURF Trial","status":"UNKNOWN","sponsor":"VENTO GIOVANNI","startDate":"2021-12-01","conditions":"Bronchopulmonary Dysplasia, Chronic Pulmonary Insufficiency of Prematurity","enrollment":20},{"nctId":"NCT04862377","phase":"PHASE3","title":"Intratracheal Budesonide With Surfactant to Prevent Bronchopulmmonary Dysplasia.","status":"NOT_YET_RECRUITING","sponsor":"Hospital Clinic of Barcelona","startDate":"2021-10-01","conditions":"Bronchopulmonary Dysplasia, Respiratory Distress Syndrome in Premature Infant, Prematurity","enrollment":50},{"nctId":"NCT05024435","phase":"NA","title":"Evaluation of Semi-rigid and Flexible Catheters for Less Invasive Surfactant Administration in Preterm Infants","status":"COMPLETED","sponsor":"Salzburger Landeskliniken","startDate":"2019-11-01","conditions":"Neonatology, Perinatal Distress Syndrome","enrollment":31},{"nctId":"NCT02611284","phase":"NA","title":"Less Invasive Beractant Administration in Preterm Infants","status":"COMPLETED","sponsor":"Hospital General Universitario Gregorio Marañon","startDate":"2013-10","conditions":"Infant, Premature","enrollment":60},{"nctId":"NCT04199364","phase":"PHASE4","title":"Medium vs Low Oxygen Threshold for the Surfactant Administration","status":"UNKNOWN","sponsor":"Virgilio Paolo Carnielli","startDate":"2021-06-01","conditions":"Respiratory Distress Syndrome","enrollment":200},{"nctId":"NCT03959384","phase":"PHASE3","title":"Efficacy and Safety of Curosurf® in Patients Invasively Ventilated for Severe Bronchiolitis Under 12 Months of Age","status":"TERMINATED","sponsor":"Azienda Ospedaliera Universitaria Integrata Verona","startDate":"2019-01-09","conditions":"Bronchiolitis, Viral","enrollment":9},{"nctId":"NCT04073173","phase":"PHASE4","title":"Stress Assessment With and Without Analgesia During Surfactant Therapy in Preterm Infants.","status":"UNKNOWN","sponsor":"Virgilio Paolo Carnielli","startDate":"2020-11-01","conditions":"Respiratory Distress Syndrome in Premature Infants","enrollment":80},{"nctId":"NCT01651637","phase":"PHASE1","title":"First In Human Study on Synthetic Surfactant CHF 5633 in Respiratory Distress Syndrome","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2012-10","conditions":"Respiratory Distress Syndrome in Premature Infants","enrollment":40},{"nctId":"NCT03846960","phase":"NA","title":"Surfactant Administration Via Thin Catheter Using a Specially Adapted Video Laryngoscope","status":"UNKNOWN","sponsor":"HaEmek Medical Center, Israel","startDate":"2019-11-01","conditions":"Respiratory Distress Syndrome","enrollment":20},{"nctId":"NCT04126382","phase":"PHASE2","title":"LISA vs INSURE in the Treatment of Respiratory Distress Syndrome in Preterm Infants","status":"UNKNOWN","sponsor":"Anhui Provincial Hospital","startDate":"2020-01-01","conditions":"Preterm Infants","enrollment":200},{"nctId":"NCT04077333","phase":"NA","title":"MISA to NRDS：a Multicenter Study in China","status":"COMPLETED","sponsor":"Peking University Third Hospital","startDate":"2017-07-01","conditions":"Bronchopulmonary Dysplasia, Patent Ductus Arteriosus, Intraventricular Hemorrhage","enrollment":237},{"nctId":"NCT01042600","phase":"PHASE4","title":"Randomized Controlled Trial of Surfactant Delivery Via Laryngeal Mask Airway (LMA) Versus Endotracheal Intubation","status":"COMPLETED","sponsor":"Albany Medical College","startDate":"2009-12","conditions":"Respiratory Distress Syndrome, Newborn","enrollment":61},{"nctId":"NCT04019106","phase":"PHASE1, PHASE2","title":"Budesonide With Intratracheal Surfactants in Extremely Preterm Infants","status":"UNKNOWN","sponsor":"University of Manitoba","startDate":"2019-10-15","conditions":"Bronchopulmonary Dysplasia, Respiratory Distress Syndrome in Premature Infant","enrollment":30},{"nctId":"NCT00233324","phase":"PHASE3","title":"Surfactant Positive Airway Pressure and Pulse Oximetry Trial","status":"COMPLETED","sponsor":"NICHD Neonatal Research Network","startDate":"2005-02","conditions":"Infant, Newborn, Diseases, Other Preterm Infants, Infant, Small for Gestational Age","enrollment":1316},{"nctId":"NCT01203358","phase":"PHASE2, PHASE3","title":"Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome","status":"COMPLETED","sponsor":"NICHD Neonatal Research Network","startDate":"1991-01","conditions":"Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age","enrollment":617},{"nctId":"NCT02482766","phase":"NA","title":"Efficacy of a New Technique -\"IN-REC-SUR-E\"- in Preterm Neonates With RDS","status":"COMPLETED","sponsor":"Catholic University of the Sacred Heart","startDate":"2015-11","conditions":"Respiratory Distress Syndrome, Hyaline Membrane Disease","enrollment":206},{"nctId":"NCT01709409","phase":"PHASE3","title":"A Multi-center Trial to Determine if Curosurf® Reduces the Duration of Mechanical Ventilation in Very Preterm Infants","status":"COMPLETED","sponsor":"Ottawa Hospital Research Institute","startDate":"2013-03","conditions":"Respiratory Distress Syndrome","enrollment":88},{"nctId":"NCT01116921","phase":"NA","title":"Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2011-02","conditions":"Respiratory Distress Syndrome","enrollment":103},{"nctId":"NCT02825953","phase":"NA","title":"Does The Surfactant Administration by Aerosolization Effective?","status":"UNKNOWN","sponsor":"nihat demir","startDate":"2016-01","conditions":"Respiratory Distress Syndrome, Surfactant Administration by Aerosolization","enrollment":75},{"nctId":"NCT02774044","phase":"PHASE2, PHASE3","title":"Efficacy and Safety of Goat Lung Surfactant for the Treatment of Respiratory Distress Syndrome in Preterm Neonates","status":"UNKNOWN","sponsor":"Ramesh K Agarwal","startDate":"2016-06","conditions":"Respiratory Distress Syndrome","enrollment":900},{"nctId":"NCT01306240","phase":"PHASE3","title":"Surfactant Versus Nasal Continuous Positive Airway Pressure (nCPAP) for Respiratory Distress Syndrome in the Newborn ≥ 35 Weeks of Gestation","status":"TERMINATED","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2011-03","conditions":"Acute Respiratory Distress Syndrome","enrollment":19},{"nctId":"NCT01310621","phase":"NA","title":"Comparison Of Surfactant Lung Lavage With Standard Care In The Treatment Of Meconium Aspiration Syndrome","status":"COMPLETED","sponsor":"Lady Hardinge Medical College","startDate":"2011-01","conditions":"Meconium Aspiration Syndrome","enrollment":60},{"nctId":"NCT01848262","phase":"NA","title":"ECALMIST Versus InSurE in Preterm Infant < 32 Weeks,Multicenter, Multinational RCT","status":"UNKNOWN","sponsor":"University of Manitoba","startDate":"2013-06","conditions":"Respiratory Distress Syndrome","enrollment":100},{"nctId":"NCT01860014","phase":"NA","title":"Comparison of Two Different Natural Surfactants in the Treatment of Pulmonary Hemorrhage","status":"COMPLETED","sponsor":"Dr. Sami Ulus Children's Hospital","startDate":"2010-03","conditions":"Pulmonary Hemorrhage","enrollment":20},{"nctId":"NCT01723683","phase":"PHASE2","title":"Minimally Invasive Surfactant Therapy Followed by CPAP (MISTCPAP) in Preterm Infants With RDS","status":"UNKNOWN","sponsor":"China Medical University Hospital","startDate":"2012-02","conditions":"Respiratory Distress Syndrome","enrollment":60},{"nctId":"NCT00883532","phase":"PHASE4","title":"Prevention of Chronic Lung Disease (CLD) in Preterm Infants","status":"UNKNOWN","sponsor":"China Medical University, China","startDate":"2009-04","conditions":"Respiratory Distress Syndrome, Chronic Lung Disease of Prematurity","enrollment":300},{"nctId":"NCT00215540","phase":"PHASE2","title":"SURFAXIN® Treatment for Prevention of Bronchopulmonary Dysplasia (BPD) in Very Low Birth Weight (VLBW) Infants.","status":"TERMINATED","sponsor":"Windtree Therapeutics","startDate":"2005-02","conditions":"Respiratory Distress Syndrome, Newborn, Premature Birth, Bronchopulmonary Dysplasia","enrollment":136},{"nctId":"NCT00578734","phase":"PHASE2","title":"Lucinactant for Treatment of Acute Hypoxemic Respiratory Failure in Children up to Two Years Old","status":"COMPLETED","sponsor":"Windtree Therapeutics","startDate":"2007-06","conditions":"Acute Hypoxemic Respiratory Failure","enrollment":165},{"nctId":"NCT01473264","phase":"PHASE1, PHASE2","title":"Safety, Pk and Anti-inflammatory Effects of CC10 Protein in Premature Infants With Respiratory Distress Syndrome (RDS)","status":"COMPLETED","sponsor":"Clarassance, Inc.","startDate":"2000-01","conditions":"Respiratory Distress Syndrome in Premature Infant, Bronchopulmonary Dysplasia","enrollment":22},{"nctId":"NCT00767039","phase":"PHASE4","title":"Curosurf and Survanta Treatment(CAST)of RDS in Very Premature Infants","status":"TERMINATED","sponsor":"Alan Fujii","startDate":"2005-01","conditions":"Prematurity, Respiratory Distress Syndrome, Patent Ductus Arteriosus","enrollment":52},{"nctId":"NCT01265589","phase":"PHASE3","title":"Intratracheal Vitamin A Administration With Surfactant for Newborn Respiratory Distress Syndrome","status":"UNKNOWN","sponsor":"Third Military Medical University","startDate":"2012-01","conditions":"RDS, Infant, Newborn, Vitamin A","enrollment":100},{"nctId":"NCT01173237","phase":"PHASE4","title":"Efficacy Evaluation of Surfactant Administration Via Laryngeal Mask Airway","status":"UNKNOWN","sponsor":"Federal University of Minas Gerais","startDate":"2011-07","conditions":"Respiratory Distress Syndrome, Newborn","enrollment":60},{"nctId":"NCT01329432","phase":"PHASE4","title":"Surfactant Administration During Spontaneous Breathing","status":"UNKNOWN","sponsor":"Zekai Tahir Burak Women's Health Research and Education Hospital","startDate":"2010-12","conditions":"Pneumothorax, Pulmonary Interstitial Emphysema, Bronchopulmonary Dysplasia","enrollment":100},{"nctId":"NCT01268215","phase":"PHASE2","title":"Pilot Study of Topical Steroid for Prevention of Chronic Lung Disease in Extremely Premature Infants.","status":"UNKNOWN","sponsor":"East Carolina University","startDate":"2010-07","conditions":"Bronchopulmonary Dysplasia","enrollment":45},{"nctId":"NCT00563641","phase":"PHASE3","title":"Very Early Surfactant and NCPAP for Premature Infants With RDS","status":"COMPLETED","sponsor":"Colombian Neonatal Research Network","startDate":"2004-01","conditions":"Respiratory Distress Syndrome, Pneumothorax/Pulmonary Intersticial Emphysema, Chronic Lung Disease","enrollment":278}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Intratracheal administration of surfactant","genericName":"Intratracheal administration of surfactant","companyName":"Chiesi Poland Sp. z o.o.","companyId":"chiesi-poland-sp-z-o-o","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Surfactant replacement therapy Used for Respiratory distress syndrome in preterm infants.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}